Two Indian Nationals Charged in Connection with Transnational Counterfeit Ozempic Scheme

Imported from official source

Announcement

A federal grand jury in the Middle District of Florida charged two individuals, Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, with conspiracy and smuggling related to an alleged transnational counterfeit prescription drug distribution scheme. The indictment alleges that Roy, Ramancha, and their co-conspirators sold counterfeit Ozempic to distributors in the United States at deeply discounted prices. Roy was extradited from Italy to the United States and made his initial appearance in Tampa, Florida, today. 

“Counterfeit prescription drugs — especially common ones — threaten the health and safety of every American who depends on the integrity of our pharmaceutical supply,” said Assistant Attorney General A. Tysen Duva of the Justice Department’s Criminal Division. “These defendants allegedly exploited people’s health to pay themselves. We will keep pursuing anyone who seeks to deceive American consumers with counterfeit drugs.”

“This indictment reflects our unwavering commitment to protecting Americans from potential harm from counterfeit prescription drugs,” said Assistant U.S. Attorney Christopher Murray for the Middle District of Florida. “Our office will not tolerate bad actors corrupting our pharmaceutical supply chain.” 

“While the U.S. wholesale distribution market is highly regulated, those who choose to subvert the safeguards of the legitimate drug regulatory regime and supply chain by introducing counterfeit drugs into the U.S. market put American consumers at significant risk,” said Assistant Commissioner Justin Green of the U.S. Food and Drug Administration Office of Criminal Investigations (FDA OCI). “Drug safety and quality do not begin or end at the U.S. border. FDA takes reports of possible counterfeit medicines seriously and works closely with other federal agencies, foreign counterparts, and the private sector to help protect the nation's drug supply.”

This is an extract. The publication continues at the source.

Read the original at the source: https://www.justice.gov/opa/pr/two-indian-nationals-charged-connection-transnational-counterfeit-ozempic-scheme

Officially imported this from DOJ Criminal Division’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
DOJ Criminal Division — imported from official source
Official source
https://www.justice.gov/news/rss?type=press_release&field_component=451 RSS
Imported
October 03, 2026 20:42
Versions
1 recorded
Identity
https://www.justice.gov/opa/pr/two-indian-nationals-charged-connection-transnational-co...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.